Identification of Heptapeptides Interacting with IFN-α-Sensitive CML cellsExpert Opinion on Investigational Drugs
AbstractBACKGROUND: Interferon-alpha (IFN-α) is the traditional therapeutic agent for chronic myeloid leukemia (CML). The molecular mechanism of IFN-α efficacy in the treatment of CML is not fully clear. OBJECTIVES: To identify the peptides and/or proteins that bind to the proteins specifically expressed on the surface of IFN-α-sensitive CML cells by using a phage display library. DESIGN/METHODS: IFN-α-sensitive KT-1/A3 cells were used as the target, and IFN-α-resistant subline KT-1/A3R was used as absorber for phage display biopanning. The positive phage clones were identified by enzyme-linked immunosorbent assay and flow cytometry. The peptides were deduced from their DNA sequences. RESULTS: Multiple clones showed high binding efficiency to KT-1/A3 cells compared with that of the other leukemia cells. One of the peptides, KLWVIPQ, has a partial amino acid sequence homology with the C-terminal domain of E3 ubiquitin-protein ligase. CONCLUSIONS: This study presents the identification of specific heptapeptides that bind to IFN-α-sensitive KT-1/A3 cells. The cancer-selective ligands provide novel strategies for early and differential diagnoses, as well as potential targeted drug delivery.
Citation InformationJia Liu, Hanchun Chen, Zhou-zhou Rao, Md. Asaduzzaman Khan, et al.. "Identification of Heptapeptides Interacting with IFN-α-Sensitive CML cells" Expert Opinion on Investigational Drugs Vol. 20 Iss. 12 (2011) p. 1583 - 1589
Available at: http://works.bepress.com/dianzheng_zhang/11/